Drugs

Alzheimer's Disease: The Risks and The Research


Alzheimer’s Disease is one of the biggest public health concerns of our time. At Alliance, we’ve seen first hand the devastating affects of this disease. Our dedication to supporting Alzheimer’s research will continue until a cure is discovered. In the meantime, we thought we’d share a few recent advancements in the field and how our clients can participate.

Identifying Alzheimer’s Risk Factors:

We published a post last year about the importance of knowing your risk for Alzheimer’s disease. Since then, experts have created a new checklist for early identification of dementia, including Alzheimer’s. This new checklist expands beyond changes in memory and considers mood, personality and behavior deviations that can occur very early in cognitive disease.

Experts are using this checklist to propose a new diagnosis, called mild behavioral impairment (MBI). Most people think of Alzheimer’s as a memory disorder, but the disease starts, in many cases, as a behavioral issue. It’s been shown that people who experience behavioral changes may develop full-fledged dementia faster and more intensely than those who do not. MBI could precede mild cognitive impairment and urge healthcare providers to begin treatment sooner.

You can see a draft of this new checklist here.

Medications On The Horizon:

A recent experimental drug, named LMTX, created by TauRx Pharmaceutical in the United Kingdom, proved to benefit a small group of patients who were not currently taking other approved Alzheimer’s medications. Ultimately, the drug failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer’s disease, but important information was discovered.

Results of this trial have helped researchers understand more about the Alzheimer’s-related protein, tau. Tau is responsible for forming tangles of nerve fibers that damage cognitive functioning. The creation of tau-related drugs is exciting, as current treatment methods, targeting beta-amyloid proteins (a protein that forms plaques in the brain), have been unsuccessful.

We encourage all clients and their loved ones suffering from dementia to be proactive in the fight against Alzheimer’s. Visit the Alzheimer’s Association Trial Match web page to search current research studies, find a match that suits your circumstance, and volunteer to participate.

Share:

More blog posts

  • feature-about-us

    Elevating Care: A Guide to Transitioning from Hospital to In-Home Nursing

    While at times necessary for your loved one’s health, a hospital stay takes a serious toll on their emotional and…

    View Article

  • What Causes Parkinson’s Disease and is it Hereditary?

    Defining Parkinson’s Disease  Parkinson’s Disease is a neurodegenerative disorder that affects movement and can cause tremors, rigidity, and difficulty with…

    View Article

  • Exercises for Parkinson's patients

    5 Best Exercises for Parkinson’s Disease Patients

    Improving Mobility and Balance Living with Parkinson’s disease poses unique challenges for many individuals, mobility and balance being two of…

    View Article

  • The Value of a Long-Term Care Plan 

    As your loved ones continue to age, your family is likely to face increasingly complex decisions regarding how best to…

    View Article

Join Our Team Calling great HHAs, RNs & LPNs

Find a career where your time and skills are valued and your dedication to service is rewarded.

Request Care

"*" indicates required fields

Name*
Address
Hidden
This field is for validation purposes and should be left unchanged.

We accept Private Pay and Private Long term Care Insurance only. We do not participate in Medicaid or Medicare Plans.

Join our team Calling great HHAs, RNs & LPNs